Glaukos Corp

Common Name
Glaukos
Country
United States
Sector
Healthcare
Industry
Medical Devices
Employees
995
Ticker
GKOS
Exchange
NEW YORK STOCK EXCHANGE, INC.
Description
Glaukos Corporation is a medical technology company dedicated to the development and commercialization of innovative products for the treatment of glaucoma, corneal disorders, and retinal diseases. It...

Glaukos's GHG Emissions Data Preview

In 2024, Glaukos completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Glaukos has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Location-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Download Data

Verified Sources Behind Glaukos’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Glaukos’s data sources below and access millions more through our Disclosure Search.

a. Glaukos's Sustainability Report 2024
a. Glaukos's Sustainability Report 2024

Insights into Glaukos's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Glaukos amounted to 3,058.6 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Glaukos increased by 11.84%, suggesting that the company faced challenges in reducing its emissions from its core operations. a

Glaukos's Scope 1 Emissions Over Time

2022202320240150300450600tCO2e+1%-9%
  • Total Scope 1
  • Year-over-Year Change

What are Glaukos's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Glaukos were 523.3 metric tons of CO₂ equivalent (tCO₂e). a

Has Glaukos reduced its Scope 1 emissions over time?

Since 2022, Glaukos's Scope 1 emissions have decreased by 8.1%, reflecting a declining long-term trend in Scope 1 emissions over time. a

Compared to the previous year (2023), Glaukos's Scope 1 emissions decreased by 9.05%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a

What are Glaukos's Scope 2 emissions?

In 2024, Glaukos reported Scope 2 greenhouse gas (GHG) emissions of 2,535.3 tCO₂e using the location-based method. a

Has Glaukos reduced its Scope 2 emissions over time?

Since 2022, Glaukos's Scope 2 greenhouse gas (GHG) emissions ( Location-Based) have increased by 86.39%, reflecting a rising long-term trend in Scope 2 emissions over time. a

Compared to the previous year (2023), Glaukos's Scope 2 emissions (Location-Based) rose by 17.41% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a

What methodology does Glaukos use for Scope 2 reporting?

In 2024, Glaukos reported its Scope 2 emissions using the location-based method. a

Glaukos's Scope 2 Emissions Over Time

20222023202406501.3 k1.95 k2.6 ktCO2e
  • Total Scope 2 Location-Based

Insights into Glaukos’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Glaukos reported Scope 1 greenhouse gas (GHG) emissions of 523.3 tCO₂e and total revenues of USD 383 millions. This translates into an emissions intensity of 1.36 tCO₂e per millions USD. a

Glaukos's Scope 1 Emissions Intensity Compared to Peers

205005,000100,0002,000,000Scope 1 Emissions (tCO2e)1005005,00020,000100,000Revenues (Millions of USD)IInteger HoldingsYear: 2023Scope 1: 7,066 tCO2eRevenue: $M 1,597Scope 1 Intensity: 4.43 tCO2e/$MAbbott LaboratoriesYear: 2024Scope 1: 502,000 tCO2eRevenue: $M 41,950Scope 1 Intensity: 11.97 tCO2e/$MInsmedYear: 2024Scope 1: 1,666 tCO2eRevenue: $M 364Scope 1 Intensity: 4.58 tCO2e/$MInsuletYear: 2024Scope 1: 1,383 tCO2eRevenue: $M 2,072Scope 1 Intensity: 0.67 tCO2e/$MBio Rad LaboratoriesYear: 2022Scope 1: 21,216 tCO2eRevenue: $M 2,802Scope 1 Intensity: 7.57 tCO2e/$MInspire Medical SystemsYear: 2023Scope 1: 51 tCO2eRevenue: $M 625Scope 1 Intensity: 0.08 tCO2e/$MFrontage HoldingsYear: 2023Scope 1: 2,883 tCO2eRevenue: $M 2,027Scope 1 Intensity: 1.42 tCO2e/$MEdwards LifesciencesYear: 2024Scope 1: 15,682 tCO2eRevenue: $M 5,439Scope 1 Intensity: 2.88 tCO2e/$MPrestige Consumer HealthcareYear: 2021Scope 1: 1,304 tCO2eRevenue: $M 943Scope 1 Intensity: 1.38 tCO2e/$MGuardant HealthYear: 2023Scope 1: 1,659 tCO2eRevenue: $M 564Scope 1 Intensity: 2.94 tCO2e/$MBrukerYear: 2022Scope 1: 3,621 tCO2eRevenue: $M 2,531Scope 1 Intensity: 1.43 tCO2e/$MSotera HealthYear: 2023Scope 1: 39,206 tCO2eRevenue: $M 1,049Scope 1 Intensity: 37.36 tCO2e/$MStrykerYear: 2023Scope 1: 54,854 tCO2eRevenue: $M 20,498Scope 1 Intensity: 2.68 tCO2e/$MRepligenYear: 2023Scope 1: 2,236 tCO2eRevenue: $M 632Scope 1 Intensity: 3.54 tCO2e/$MZimmer Biomet HoldingsYear: 2024Scope 1: 10,191 tCO2eRevenue: $M 7,679Scope 1 Intensity: 1.33 tCO2e/$MIIIntegra Lifesciences HoldingsYear: 2024Scope 1: 14,555 tCO2eRevenue: $M 1,611Scope 1 Intensity: 9.04 tCO2e/$MDexcomYear: 2023Scope 1: 5,383 tCO2eRevenue: $M 3,622Scope 1 Intensity: 1.49 tCO2e/$MBoston ScientificYear: 2024Scope 1: 87,567 tCO2eRevenue: $M 16,747Scope 1 Intensity: 5.23 tCO2e/$MQuidelOrthoYear: 2023Scope 1: 22,544 tCO2eRevenue: $M 2,998Scope 1 Intensity: 7.52 tCO2e/$MIonis PharmaceuticalsYear: 2024Scope 1: 2,616 tCO2eRevenue: $M 705Scope 1 Intensity: 3.71 tCO2e/$MGlaukosYear: 2024Scope 1: 523 tCO2eRevenue: $M 383Scope 1 Intensity: 1.36 tCO2e/$M

How does Glaukos's GHG emissions intensity compare to its peers?

In 2024, Glaukos reported a Scope 1 emissions intensity of 1.36 tCO₂e per millions USD. Compared to the peer group median of 3.24 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Glaukos rank on GHG emissions intensity within its industry?

In 2024, Glaukos ranked 4 out of 20 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

This places Glaukos among the top performers, with one of the lowest emissions intensities relative to peers. a

Want Full Access to Glaukos's GHG Emissions Dataset?
Sign Up